Andrew Hemmert
April 26, 2024
Dr. Andrew Hemmert is the Senior Vice President of Molecular Research and Development for bioMérieux. Based in Salt Lake City, Andrew leads global teams focused on the creation of easy-to-use, rapid, and comprehensive molecular diagnostics. bioMérieux innovations to infectious disease diagnostics from these teams include the largest available menu for respiratory, blood stream, gastrointestinal, central nervous system, and skeletal infections for hospital customers. Additionally, the bioMerieux SpotFire system, delivers rapid, comprehensive results for the point of care setting. Andrew is also an active contributor to the scientific community through multiple publications, grants, and patents.
Recent News
- Rep. Celeste Maloy Tours BIOS, Neurotech Innovation
- U.S. FDA Accepts Teva’s New Drug Application (NDA) and Grants Priority Review for Ecopipam for Pediatric Patients with Tourette Syndrome
- Sera Prognostics Appoints Scott Gleason CFO
- Merit Medical Announces Global Operations Leadership Transition
- Utah Life Sciences Innovation Caucus Breakfast
- Curavit Expands Clinical Research Capabilities with Acquisition of Lindus Health CRO Assets, Accelerating Global Trial Execution for Life Science Sponsors
